Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion Product
- 1 November 2015
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 15 (11), e157-e162
- https://doi.org/10.1016/j.clml.2015.08.085
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Adverse reactions during transfusion of thawed haematopoietic progenitor cells from apheresis are closely related to the number of granulocyte cells in the leukapheresis productVox Sanguinis, 2010
- Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cellsHaematologica, 2008
- The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis productBone Marrow Transplantation, 2007
- Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantationsBone Marrow Transplantation, 2007
- Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis productTransfusion, 2007
- Clinical side effects during peripheral blood progenitor cell infusionTransfusion and Apheresis Science, 2007
- Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient ageCytotherapy, 2007
- The effect of hematopoietic progenitor cells’ temperature on cardiac arrhythmias in patients given peripheral blood progenitor cellsTransfusion and Apheresis Science, 2006
- Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 casesBone Marrow Transplantation, 1999
- Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockadeCytotherapy, 1999